Mentioned in ?
References in periodicals archive ?
It will be of particular interest because, until today, technology limitations restricted our ability to monitor and treat slow VTs in HF patients without compromising the delivery of cardiac resynchronization therapy ".
Since its introduction, the Medtronic CareLink Network has facilitated the transmission of nearly 200,000 device interrogations, allowing physicians to perform a complete analysis of all the device- and patient-specific cardiac data stored within its implantable cardioverter-defibrillators (ICDs), pacemakers and cardiac resynchronization therapy (CRT) devices.
Cardiac resynchronization therapy defibrillators are indicated in advanced heart failure patients who might be at risk for Sudden Cardiac Death (SCD).
11, 2014 /PRNewswire/ -- Global Market Watch: Global Cardiac Resynchronization Therapy (CRT) sector is projected to reach US$3.
BIOTRONIK today announced the market release of the Stratos LV[TM] Cardiac Resynchronization Therapy pacemaker (CRT-P).
Cardiac Resynchronization Therapy Defibrillator (CRT-D) - (CRT with pacemaker and ICD function)
implant in the Investigational Trial of the OVATIO[TM] CRT, Cardiac Resynchronization Therapy Defibrillator, Model 6750.
com has added a new market research report: Cardiac Resynchronization Therapy (CRT) Devices - Emerging Markets (Brazil, Russia, India, China, South Africa And South Korea), 2012-2018 http://www.
Jude Medical's (NYSE:STJ) QuickOpt([TM]) Timing Cycle Optimization is equivalent to traditional echocardiography (echo) in optimizing implantable cardioverter defibrillators (ICDs) and cardiac resynchronization therapy defibrillators (CRT-Ds), but requires less time and effort.
2 Cardiac Resynchronization Therapy Increasingly Popular Around the World 67 4.
a Sorin Group (MIL:SRN) Company and a member of the Sorin Group Cardiac Rhythm Management (CRM) Business Unit, today announced that it has filed a pre-market approval application (PMA) with the United States Food and Drug Administration (FDA) seeking approval to market OVATIO[TM] CRT, its latest cardiac resynchronization therapy defibrillator (CRT-D).